These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Quantitative evaluation of cellular uptake, DNA incorporation and adduct formation in cisplatin sensitive and resistant cell lines: Comparison of different Pt-containing drugs. Corte-Rodríguez M; Espina M; Sierra LM; Blanco E; Ames T; Montes-Bayón M; Sanz-Medel A Biochem Pharmacol; 2015 Nov; 98(1):69-77. PubMed ID: 26352094 [TBL] [Abstract][Full Text] [Related]
6. Distinct mechanisms contribute to acquired cisplatin resistance of urothelial carcinoma cells. Höhn A; Krüger K; Skowron MA; Bormann S; Schumacher L; Schulz WA; Hoffmann MJ; Niegisch G; Fritz G Oncotarget; 2016 Jul; 7(27):41320-41335. PubMed ID: 27191498 [TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of Gd@C82(OH)22 and cisplatin uptake in single cells by inductively coupled plasma mass spectrometry. Zheng LN; Wang M; Zhao LC; Sun BY; Wang B; Chen HQ; Zhao YL; Chai ZF; Feng WY Anal Bioanal Chem; 2015 Mar; 407(9):2383-91. PubMed ID: 25701412 [TBL] [Abstract][Full Text] [Related]
9. Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. Federici C; Petrucci F; Caimi S; Cesolini A; Logozzi M; Borghi M; D'Ilio S; Lugini L; Violante N; Azzarito T; Majorani C; Brambilla D; Fais S PLoS One; 2014; 9(2):e88193. PubMed ID: 24516610 [TBL] [Abstract][Full Text] [Related]
10. Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin. Tang CH; Parham C; Shocron E; McMahon G; Patel N Cancer Chemother Pharmacol; 2011 Jun; 67(6):1389-400. PubMed ID: 20809122 [TBL] [Abstract][Full Text] [Related]
11. Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature. Barr MP; Gray SG; Hoffmann AC; Hilger RA; Thomale J; O'Flaherty JD; Fennell DA; Richard D; O'Leary JJ; O'Byrne KJ PLoS One; 2013; 8(1):e54193. PubMed ID: 23349823 [TBL] [Abstract][Full Text] [Related]
12. Single-cell and bulk ICP-MS investigation of accumulation patterns of Pt-based metallodrugs in cisplatin-sensitive and -resistant cell models. Lim SY; Low ZE; Tan RPW; Lim ZC; Ang WH; Kubota T; Yamanaka M; Pang S; Simsek E; Li SFY Metallomics; 2022 Dec; 14(12):. PubMed ID: 36271844 [TBL] [Abstract][Full Text] [Related]
13. Combining disulfiram and poly(l-glutamic acid)-cisplatin conjugates for combating cisplatin resistance. Song W; Tang Z; Shen N; Yu H; Jia Y; Zhang D; Jiang J; He C; Tian H; Chen X J Control Release; 2016 Jun; 231():94-102. PubMed ID: 26928530 [TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-mediated delivery of multinuclear platinum(IV) prodrugs with enhanced drug uptake and the activity of overcoming drug resistance. Gao Y; Jiang M; Ma Y; Wu S; Li W; Yang X; Li Y; Jing X; Jiang H Anticancer Drugs; 2016 Feb; 27(2):77-83. PubMed ID: 26473527 [TBL] [Abstract][Full Text] [Related]
15. Interaction between the anticancer drug Cisplatin and the copper chaperone Atox1 in human melanoma cells. Palm-Espling ME; Lundin C; Björn E; Naredi P; Wittung-Stafshede P Protein Pept Lett; 2014; 21(1):63-8. PubMed ID: 23988033 [TBL] [Abstract][Full Text] [Related]
17. Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity. Gibalová L; Sedlák J; Labudová M; Barancík M; Reháková A; Breier A; Sulová Z Gen Physiol Biophys; 2009 Dec; 28(4):391-403. PubMed ID: 20097962 [TBL] [Abstract][Full Text] [Related]
18. Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat. To KK; Tong WS; Fu LW Lung Cancer; 2017 Jan; 103():58-65. PubMed ID: 28024697 [TBL] [Abstract][Full Text] [Related]
19. Differences in cisplatin distribution in sensitive and resistant ovarian cancer cells: a TEM/NanoSIMS study. Lee RFS; Riedel T; Escrig S; Maclachlan C; Knott GW; Davey CA; Johnsson K; Meibom A; Dyson PJ Metallomics; 2017 Oct; 9(10):1413-1420. PubMed ID: 28913538 [TBL] [Abstract][Full Text] [Related]
20. Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro. Palm ME; Weise CF; Lundin C; Wingsle G; Nygren Y; Björn E; Naredi P; Wolf-Watz M; Wittung-Stafshede P Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6951-6. PubMed ID: 21482801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]